Vaccines

17 Apr 2008 Alphavax announces initial analysis of data from CMV phase I clinical trial
17 Apr 2008 Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
16 Apr 2008 Novavax Reports Positive Results from Preclinical Studies of its VLP-based
16 Apr 2008 Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
15 Apr 2008 Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
14 Apr 2008 Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies
11 Apr 2008 Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for Prostate Cancer in Recurrent Disease
10 Apr 2008 Post-exposure vaccination with IMVAMUNE(R) protects against lethal poxvirus infection
09 Apr 2008 Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
08 Apr 2008 Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
04 Apr 2008 FDA Approves ROTARIX(R) Rotavirus Vaccine
04 Apr 2008 Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System
03 Apr 2008 Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
03 Apr 2008 Crucell Announces First in Man Study with New Adenovirus Vector
02 Apr 2008 Yondelis (R) has been granted orphan drug status by the swiss agency for therapeutic products (Swissmedic) for the treatment of soft tissue sarcoma and ovarian cancer
02 Apr 2008 Sinovac Biotech Ltd. (SNVBF) Receives SFDA Approval for Pandemic Influenza H5N1 Vaccine
01 Apr 2008 AVANT's Single-Dose Oral Ty800 Vaccine Meets Primary Endpoints in Phase 2 Study
31 Mar 2008 Sharing of Sabin-IPV Seed Virus by Japan Poliomyelitis Research Institute with Takeda and Grant of Right to Its Commercialization
31 Mar 2008 Cell Genesys and Takeda Announce Global Alliance for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer
25 Mar 2008 Oxford BioMedica Report Encouraging New Phase II Trial Results With TroVax(R) in Prostate Cancer
20 Mar 2008 Acambis extends Sanofi Pasteur licensing agreement on single-dose JE vaccine to India and Indian subcontinent
20 Mar 2008 Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
20 Mar 2008 Pharmathene signs definitive agreement to acquire Biodefense vaccines business from Avecia
19 Mar 2008 GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients with Non-Small Cell Lung Cancer at Memorial Sloan Kettering
19 Mar 2008 Medicago’s H5N1 VLP vaccine provides protection against multiple strains of avian flu

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top